health claim
CRN Responds to Cholesterol Study That Compares Supplements to Prescription Drug
by Shari Barbanel |
November 9, 2022
The Council for Responsible Nutrition (CRN) has responded to results of the “Supplements, Placebo, or Rosuvastatin (SPORT)” Study. It was presented at the American Heart Association Scientific Sessions Nov. 6. SPORT, and funded by AstraZeneca, the company that markets Rosuvastatin. The study compared the effect on low-density lipoprotein-cholesterol (LDL-C) from the funder’s low-dose statin with ...
Don't Miss Out!
Digital Newsletter
Natural Practitioner Magazine
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Natural Practitioner magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
